The world’s largest-ever clinical trial of treatments to slow or stop the progression of Parkinson’s disease has launched, led by researchers at UCL and Newcastle University.
The £26 million project is accelerating the search for…
The world’s largest-ever clinical trial of treatments to slow or stop the progression of Parkinson’s disease has launched, led by researchers at UCL and Newcastle University.
The £26 million project is accelerating the search for…
If you’re looking for a multi-bagger, there’s a few things to keep an eye out for. Ideally, a business will show two trends; firstly a growing return on capital employed (ROCE) and secondly, an increasing amount of capital employed. This shows us that it’s a compounding machine, able to continually reinvest its earnings back into the business and generate higher returns. However, after briefly looking over the numbers, we don’t think Yew Lee Pacific Group Berhad (KLSE:YEWLEE) has the makings of a multi-bagger going forward, but let’s have a look at why that may be.
AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part – they are all under $10bn in marketcap – there is still time to get in early.
For those that aren’t sure what ROCE is, it measures the amount of pre-tax profits a company can generate from the capital employed in its business. Analysts use this formula to calculate it for Yew Lee Pacific Group Berhad:
Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets – Current Liabilities)
0.011 = RM832k ÷ (RM81m – RM2.8m) (Based on the trailing twelve months to June 2025).
Thus, Yew Lee Pacific Group Berhad has an ROCE of 1.1%. Ultimately, that’s a low return and it under-performs the Building industry average of 8.9%.
Check out our latest analysis for Yew Lee Pacific Group Berhad
While the past is not representative of the future, it can be helpful to know how a company has performed historically, which is why we have this chart above. If you’re interested in investigating Yew Lee Pacific Group Berhad’s past further, check out this free graph covering Yew Lee Pacific Group Berhad’s past earnings, revenue and cash flow.
On the surface, the trend of ROCE at Yew Lee Pacific Group Berhad doesn’t inspire confidence. Around five years ago the returns on capital were 28%, but since then they’ve fallen to 1.1%. And considering revenue has dropped while employing more capital, we’d be cautious. If this were to continue, you might be looking at a company that is trying to reinvest for growth but is actually losing market share since sales haven’t increased.
On a related note, Yew Lee Pacific Group Berhad has decreased its current liabilities to 3.5% of total assets. That could partly explain why the ROCE has dropped. What’s more, this can reduce some aspects of risk to the business because now the company’s suppliers or short-term creditors are funding less of its operations. Some would claim this reduces the business’ efficiency at generating ROCE since it is now funding more of the operations with its own money.
Every day, your brain makes thousands of decisions under uncertainty. Most of the time, you guess right. When you don’t, you learn. But when the brain’s ability to judge context or assign meaning falters, thoughts and behavior can…
Anthropic PBC wants to make artificial intelligence agents more effective when it comes to doing real work, and its latest idea is to provide them with additional “skills” that can help them when assigned a very specific task.
The…
Orlando Health researchers have identified widespread public misconceptions about obstetrics care based on results of a recent survey.1
These misconceptions include 54% of US individuals believing women cannot safely give birth in their 40s, and…
In a series of experiments using mouse models of breast, pancreatic, and muscle cancers, scientists at Johns Hopkins All Children’s Hospital uncovered new evidence that strengthening the body’s natural immune defenses can both prevent cancer from…
Dengue has been a public health problem in the tropical world for decades and 2024 saw a global dengue surge, with more than 14 million cases and 10 thousand deaths reported worldwide – more than more double the figures for dengue…
Pulmonary fibrosis is a deadly disease in which the lungs become thickened and scarred, gradually losing their ability to deliver oxygen to the body. Now, scientists at UC San Francisco have identified a key cellular switch that drives…
Pressing challenges like climate change require a coordinated, multilateral response. So too does the trend of economic nationalism spreading around the world. A multilateral green trade pact focused on decarbonising heavy industries and…
Bolton is now the third Trump adversary prosecuted in the last…